Cargando…
Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
BACKGROUND: Cardiovascular disease (CVD) influences phenotypic variation in Parkinson's disease (PD), and is usually an indication for statin therapy. It is less clear whether cardiovascular risk factors influence PD phenotype, and if statins are prescribed appropriately. OBJECTIVES: To quantif...
Autores principales: | Swallow, Diane M A, Lawton, Michael A, Grosset, Katherine A, Malek, Naveed, Klein, Johannes, Baig, Fahd, Ruffmann, Claudio, Bajaj, Nin P, Barker, Roger A, Ben-Shlomo, Yoav, Burn, David J, Foltynie, Thomas, Morris, Huw R, Williams, Nigel, Wood, Nicholas W, Hu, Michele T M, Grosset, Donald G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116532/ https://www.ncbi.nlm.nih.gov/pubmed/27671901 http://dx.doi.org/10.1136/jnnp-2016-313642 |
Ejemplares similares
-
Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022) -
Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018) -
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018) -
Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022) -
Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
por: Lawton, Michael, et al.
Publicado: (2015)